NEW YORK (GenomeWeb News) – Agilent Technologies reported after the close of the market on Thursday that revenues for the first quarter of its Fiscal Year 2014 were flat year over year while Life Sciences and Diagnostics revenues ticked up 5 percent.

For the three months ended Jan. 31, total revenues of $1.68 billion narrowly missed the consensus Wall Street estimate of $1.69 billion. Orders of $1.68 billion were down 2 percent from $1.71 billion a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.